[go: up one dir, main page]

ATE357915T1 - USE OF HYDROXYPYRIDONE DERIVATIVES FOR WOUND HEALING - Google Patents

USE OF HYDROXYPYRIDONE DERIVATIVES FOR WOUND HEALING

Info

Publication number
ATE357915T1
ATE357915T1 AT03718739T AT03718739T ATE357915T1 AT E357915 T1 ATE357915 T1 AT E357915T1 AT 03718739 T AT03718739 T AT 03718739T AT 03718739 T AT03718739 T AT 03718739T AT E357915 T1 ATE357915 T1 AT E357915T1
Authority
AT
Austria
Prior art keywords
wound healing
hydroxypyridone derivatives
hydroxypyridone
derivatives
wounds
Prior art date
Application number
AT03718739T
Other languages
German (de)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Roland H Wenger
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE357915T1 publication Critical patent/ATE357915T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the use of compounds of the formula I, <CHEM> in which R<1>; R<2>; R<3> and R<4> have the meanings indicated in the claims, for the treatment of wounds.
AT03718739T 2002-04-20 2003-04-08 USE OF HYDROXYPYRIDONE DERIVATIVES FOR WOUND HEALING ATE357915T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02008902A EP1354586A1 (en) 2002-04-20 2002-04-20 The use of hydroxpyridone-derivatives in wound healing

Publications (1)

Publication Number Publication Date
ATE357915T1 true ATE357915T1 (en) 2007-04-15

Family

ID=28459510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03718739T ATE357915T1 (en) 2002-04-20 2003-04-08 USE OF HYDROXYPYRIDONE DERIVATIVES FOR WOUND HEALING

Country Status (16)

Country Link
US (1) US20040014794A1 (en)
EP (2) EP1354586A1 (en)
JP (1) JP4709489B2 (en)
AT (1) ATE357915T1 (en)
AU (1) AU2003222802B2 (en)
BR (1) BR0309403A (en)
CA (1) CA2482972C (en)
CY (1) CY1106472T1 (en)
DE (1) DE60312840T2 (en)
DK (1) DK1499312T3 (en)
ES (1) ES2282615T3 (en)
IL (1) IL164536A (en)
MX (1) MXPA04009186A (en)
PT (1) PT1499312E (en)
SI (1) SI1499312T1 (en)
WO (1) WO2003088966A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009044403A2 (en) 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
AU2011261499B2 (en) 2010-06-01 2015-07-16 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
GB201509847D0 (en) 2015-06-08 2015-07-22 Nautilus Biosciences Canada Inc Anti-dandruff agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322169C (en) * 1988-04-22 1993-09-14 Hiroshi Yamazaki Ionic dressing of topical administration of drugs to wounds and burns
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
FR2737118B1 (en) * 1995-07-28 1997-09-05 Oreal DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION, METHOD OF PREPARATION AND USE
DE69628050T2 (en) * 1995-10-25 2004-04-01 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
US5811078A (en) * 1997-03-14 1998-09-22 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
DE19802708A1 (en) * 1998-01-24 1999-07-29 Hoechst Marion Roussel De Gmbh Use of 1-hydroxy-2-pyridone compounds with powder base for treatment of lower leg ulcers and decubitus ulcers
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
SE521431C2 (en) * 1999-12-02 2003-11-04 Sca Hygiene Prod Ab Use of a pH buffering substance to prevent skin infections caused by Candida Albicans
EP1397484A4 (en) * 2001-03-27 2005-05-25 Massachusetts Inst Technology METHODS AND PRODUCTS RELATED TO DIMERIZATION OF FIBROBLAST GROWTH FACTORS
WO2003018014A2 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives

Also Published As

Publication number Publication date
JP2005529875A (en) 2005-10-06
EP1499312A1 (en) 2005-01-26
DE60312840D1 (en) 2007-05-10
DK1499312T3 (en) 2007-07-02
IL164536A (en) 2011-11-30
EP1354586A1 (en) 2003-10-22
CA2482972C (en) 2011-02-01
CY1106472T1 (en) 2012-01-25
EP1499312B1 (en) 2007-03-28
IL164536A0 (en) 2005-12-18
AU2003222802B2 (en) 2008-01-03
DE60312840T2 (en) 2007-12-13
PT1499312E (en) 2007-05-31
ES2282615T3 (en) 2007-10-16
CA2482972A1 (en) 2003-10-30
JP4709489B2 (en) 2011-06-22
SI1499312T1 (en) 2007-08-31
AU2003222802A1 (en) 2003-11-03
WO2003088966A1 (en) 2003-10-30
US20040014794A1 (en) 2004-01-22
BR0309403A (en) 2005-02-01
MXPA04009186A (en) 2004-11-26

Similar Documents

Publication Publication Date Title
ATE453393T1 (en) USE OF PYRIDYLAMIDE AS ANGIOGENESIS INHIBITORS
ATE495736T1 (en) USE OF DERIVATIVES OF 2-OXOTHIAZOLIDINE-4-CORBONIC ACID AS PRE-DEPENDER
IS2520B (en) Nicotinamide derivatives useful as P38 inhibitors
DE60315146D1 (en) HETEROARYLSUBSTITUTED BIPHENYL DERIVATIVES AS INHIBITORS OF P38 KINASE
ATE432072T1 (en) USE OF ADAPALEN FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
ATE408601T1 (en) FREDERICAMYCIN DERIVATIVES
ATE327753T1 (en) CARBOXYLIC ACID SUBSTITUTED OXAZOLE DERIVATIVES FOR USE AS PPAR-ALPHA AND -GAMMA ACTIVATORS FOR THE TREATMENT OF DIABETES
ATE414089T1 (en) USE OF RAPAMYCIN AND ITS DERIVATIVES FOR THE TREATMENT OF BONE LOSS
DE69200160D1 (en) Angiotensin II antagonists.
ATE336996T1 (en) USE OF FLAVONOID DERIVATIVES FOR THE TREATMENT OF ATOPIC ECZEMA
ATE384437T1 (en) N-THIO-NICOTINAMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE AS PESTOPTIC AGENTS
ATE418552T1 (en) SUBSTITUTED AMINO-FURAN-2-YL-ACETIC ACID AND AMINO-THIEN-2-YL-ACETIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF MIGRAINE AND RESPECTIVELY. PAIN
NO984950L (en) Compounds with growth hormone releasing properties
DE60129829D1 (en) CYCLED BENZAMIDE NEUROKININE ANTAGONISTS FOR USE IN THERAPY
ATE359283T1 (en) SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION
ATE402694T1 (en) USE OF 1-PHENYL-3-DIMETHYLAMINO-PROPANE COMPOUNDS FOR THE THERAPY OF URINARY INCONTINENCE
DE69307674D1 (en) HIV protease inhibitors and their use in the treatment of AIDS
DE60131968D1 (en) PYRANOE2,3-CIMIDAZOÄ1,2-ATPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
ATE357915T1 (en) USE OF HYDROXYPYRIDONE DERIVATIVES FOR WOUND HEALING
ATE361071T1 (en) USE OF IRBESARTAN TO PREVENT OR TREAT PULMONARY HYPERTENSION
ATE330596T1 (en) USE OF 3-BEZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF RETINAL DISEASES
DE60213365D1 (en) USE OF MGLUR5 ANTAGONISTS FOR THE TREATMENT OF PRITICAL CONDITIONS
ATE348611T1 (en) DERIVATIVES OF PHENOXY-N-&#39;4-(ISOTHIAZOLIDINE-1,1-DIOXIDE-2YL)PHENY)-VALERIAN ACID AMIDE AND OTHER COMPOUNDS AS COAGULATION FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES AND TUMORS
ATE275558T1 (en) 4-ARYLPIPERIDINE DERIVATIVES FOR THE TREATMENT OF PRURITUS
ATE369849T1 (en) HALOACETAMIDOBENZOIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC DISEASES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1499312

Country of ref document: EP